Pfizer's $853 Million Trading Day Sees Stock Drop 1.82% Ranking 86th Amidst COVID-19 Vaccine Updates

On May 28, 2025, Pfizer's trading volume reached $853 million, ranking 86th in the day's stock market. Pfizer's stock price fell by 1.82%.

Pfizer and BioNTech have submitted an application to the European Medicines Agency (EMA) for a COVID-19 vaccine targeting the LP.8.1 variant for the 2025-2026 season. This submission is part of their ongoing efforts to adapt to the evolving landscape of the pandemic and ensure that their vaccines remain effective against new variants.

Additionally, the companies have also submitted an application to the EMA for a variation of the Marketing Authorization (MA) to include the bivalent vaccine as a primary course of vaccination. This move is aimed at providing a more comprehensive protection against COVID-19, especially as new variants continue to emerge.